drugset / Trial / NCT02668536

A Sunscreen Based on Bioadhesive Nanoparticles

NCT02668536

Phase 1 Completed 13 enrolled Yale University
Non-randomizedParallel-groupDouble-blindPrevention

Summary

The initial focus of the study will be on safety, sun protection factor (SPF) characterization, and substantivity (duration of protection) studies. The primary outcome of the study will be to measure the sun protection factor (SPF) of a bioadhesive nanoparticles (BNP) formulation in 20-25 healthy volunteers with fair skin.

Timeline

Start
2017-07-17
Primary completion
2017-08-18
Completion
2017-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxybenzone Small molecule 3 % Topical
Subject Padimate-O Small molecule 7 % Topical